
|Videos|May 26, 2022
Choosing a Combination Therapy for Renal Cell Carcinoma Before and After CLEAR Data
Author(s)Brian Shimkus, MD, Tom Powles, MBBS, MRCP, MD
Brian Shimkus, MD, discusses how he chose between RCC combination therapies before CLEAR trial data, and how the data influences his decisions now.
Advertisement
Episodes in this series

Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
All-Oral Revumenib Regimen May Show Advantage in Newly Diagnosed AML
2
Blinatumomab/Ponatinib Provides Chemo-Free Option in Ph+ ALL
3
Epcoritamab Combo Significantly Improves Efficacy in 2L R/R Follicular Lymphoma
4
Azacitidine Plus Venetoclax Improves EFS in Acute Myeloid Leukemia
5




























































































